Tegoprazan

CAT:
804-HY-17623-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tegoprazan - image 1

Tegoprazan

  • Description:

    Tegoprazan (CJ-12420), a potassium-competitive acid blocker, is a reversible, orally active and highly selective inhibitor of gastric H+/K+-ATPase. Tegoprazan inhibits gastric acid secretion and motility against porcine, canine and human H+/K+-ATPase with IC50 values ranging from 0.29-0.52 μM in vitro. Tegoprazan significantly improves colitis and enhances the intestinal epithelial barrier function in mice. Tegoprazan is promising for research of Inflammatory bowel, gastric acid-related, motilityimpaired diseases[1][2][3].
  • Product Name Alternative:

    CJ-12420; RQ-00000004
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Na+/K+ ATPase; Potassium Channel; Proton Pump
  • Type:

    Reference compound
  • Related Pathways:

    Membrane Transporter/Ion Channel
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/Tegoprazan.html
  • Concentration:

    10mM
  • Purity:

    99.76
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    FC1=CC(F)=C2[C@@H](OC3=CC(C(N(C)C)=O)=CC4=C3N=C(C)N4)CCOC2=C1
  • Molecular Formula:

    C20H19F2N3O3
  • Molecular Weight:

    387.38
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [2]Son M, et al. Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function[J]. Front Immunol. 2022 May 25;13:870817. |[3]Kim DK, et al. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease[J]. J Pharmacol Exp Ther. 2019 Jun;369 (3) :318-327. |[1]Takahashi N, et al. Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility. J Pharmacol Exp Ther. 2018 Feb;364 (2) :275-286.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • CAS Number:

    [942195-55-3]